Insights from mouse models into the molecular basis of neurodegeneration

Annual Review of Physiology

Volumn 62, Issue , 2000, Pages 779-802

  Heintz, N ^a   Zoghbi, H Y ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Ion channel; Ischemic cell death; Neurotransmitter receptor; Polyglutamine diseases

Indexed keywords

ION CHANNEL; NEUROTRANSMITTER RECEPTOR;

BRAIN ISCHEMIA; CEREBELLAR ATAXIA; DISEASE ASSOCIATION; DISEASE MODEL; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MACHADO JOSEPH DISEASE; NERVE CELL NECROSIS; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW; SPINOCEREBELLAR DEGENERATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, NEUROLOGIC MUTANTS; NEURODEGENERATIVE DISEASES; RECEPTORS, GLUTAMATE;

EID: 0033862578     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.62.1.779     Document Type: Review

References (118)

1. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
2. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
3. Spinocerebellar ataxia Type 1
4. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
5. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations
6. Ataxin-1 with extra glutamines induces alterations in nuclear matrix- associated structures
7. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine- induced disease in SCA1 transgenic mice
8. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo
9. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
10. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
11. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
12. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse
13. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
14. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
15. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion
16. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice
17. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation
18. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
19. Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis) fold
20. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
21. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
22. Brain lesions in an infant rhesus monkey trreated with monosodium glutamate
23. Calcium and excitotoxic neuronal injury
24. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
25. Structural and quantitative studies on the normal C3H and Lurcher mutant mouse
26. Massive loss of mid- and hindbrain neurons during embryonic development of homozygous lurcher mice
27. Abnormalities in the cerebellum and brainstem in homozygous lurcher mice
28. Interaction of granule, Purkinje and inferior olivary neurons in lurcher chimeric mice. II. Granule cell death
29. Interaction of granule, Purkinje and inferior olivary neurons in lurcher chimaeric mice. I. Qualitative studies
30. Bcl-2, Bax and Bcl-x expression in neuronal apoptosis: A study of mutant weaver and lurcher mice
31. Target-related and intrinsic neuronal death in Lurcher mutant mice involve different apoptotic pathways, but are both mediated by caspase-3 activation
32. Cell death and the cell cycle: A relationship between transformation and neurodegeneration?
33. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene
34. Molecular cloning of a cDNA encoding a novel member of the mouse glutamate receptor channel family
35. The rat delta-1 and delta-2 subunits extend the excitatory amino acid receptor family
36. Selective expression of the glutamate receptor channel delta 2 subunit in cerebellar Purkinje cells
37. Immunoprecipitation, immunoblotting, and immunocytochemistry studies suggest that glutamate receptor delta subunits form novel postsynaptic receptor complexes
38. Light- and electron-microscopic localization of the glutamate receptor channel delta 2 subunit in the mouse Purkinje cell
39. Differential localization of delta glutamate receptors in the rat cerebellum: Coexpression with AMPA receptors in parallel fiber-spine synapses and absence from climbing fiber-spine synapses
40. Delta-glutamate receptors are differentially distributed at parallel and climbing fiber synapses on Purkinje cell
41. Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluR delta 2 mutant mice
42. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures
43. Overexpression of a Hu-bcl-2 transgene in Lurcher mutant mice delays Purkinje cell death
44. Postnatal expression of Hu-bcl-2 gene in Lurcher mutant mice fails to rescue Purkinje cells but protects inferior olivary neurons from target- related cell death
45. Afferent-target cell interactions in the cerebellum: Negative effect of granule cells on Purkinje cell development in lurcher mice
46. The changing landscape of ischaemic brain injury mechanisms
47. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain
48. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D- aspartate antagonist
49. 2+ channels controlling presynaptic release of glutamate
50. Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor
51. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
52. Differential regulation of Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat
53. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat
54. Expression of interleukin-1 beta converting enzyme gene family and bcl- 2 gene family in the rat brain following permanent occlusion of the middle cerebral artery
55. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
56. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia
57. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat
58. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain
59. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain
60. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats
61. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats
62. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia
63. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice
64. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
65. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice
66. Differential effects of Bcl-2 overexpression on hippocampal CA1 neurons and dentate granule cells following hypoxic ischemia in adult mice
67. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons
68. Abnormal rate of granule cell migration in the cerebellum of 'Weaver' mutant mice
69. Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice
70. Anatomical, physiological and biochemical studies of the cerebellum from mutant mice. II. Morphological study of cerebellar cortical neurons and circuits in the weaver mouse
71. Development and death of external granular layer cells in the weaver mouse cerebellum: A quantitative study
72. The weaver granuloprival phenotype is due to intrinsic action of the mutant locus in granule cells: Evidence from homozygous weaver chimeras
73. Weaver mouse cerebellar granule neurons fail to migrate on wild-type astroglial processes in vitro
74. The weaver gene encodes a nonautonomous signal for CNS neuronal differentiation
75. Dopamine deficiency in the weaver mutant mouse
76. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments
77. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. II. High affinity uptake sites for dopamine
78. Granule cell as a site of gene action in the weaver mouse cerebellum: Evidence from heterozygous mutant chimeras
79. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation
80. + channel GIRK2
81. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver
82. The weaver granuloprival phenotype is due to intrinsic action of the mutant locus in granule cells: Evidence from homozygous weaver chimeras
83. + channels
84. + channel and rescue of weaver granule cells
85. The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2
86. + current in cerebellar granule cells
87. A regenerative link in the ionic fluxes through the weaver potassium channel underlies the pathophysiology of the mutation
88. Assessment of a mutation in the H5 domain of Girk2 as a candidate for the weaver mutation
89. + channel GIRK2 in the cerebellum of normal and weaver mutant mice
90. The weaver mutation causes a loss of inward rectifier current regulation in premigratory granule cells of the mouse cerebellum
91. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic
92. Cribriform degeneration (cri): A new recessive neurological mutation in the mouse
93. Evidence for allelism of leaner and tottering in the mouse
94. Normal pharmacological and morphometric parameters in the noradrenergic hyperinnervated mutant mouse, 'tottering'
95. Tottering and leaner mutations perturb transient developmental expression of tyrosine hydroxylase in embryologically distinct Purkinje cells
96. Inherited epilepsy: Spike-wave and focal motor seizures in the mutant mouse tottering
97. Cerebellar cell degeneration in the leaner mutant mouse
98. Purkinje cell loss from alternating sagittal zones in the cerebellum of leaner mutant mice
99. Absence epilepsy in tottering mutant mice is associated with calcium channel defects
100. 2+ channel gene CACNL1A4
101. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel
102. Whole-cell and single-channel analysis of P-type calcium currents in cerebellar Purkinje cells of leaner mutant mice 17
103. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel
104. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner
105. Vestibular ganglion neurons survive the loss of their cerebellar targets
106. Purkinje cell degeneration, a new neurological mutation in the mouse
107. The development and degeneration of Purkinje cells in pcd mutant mice
108. Stability of inferior olivary neurons in rodents. I. Moderate cell loss in adult Purkinje cell degeneration mutant mouse
109. Apoptotic pathways: The roads to ruin
110. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
111. Cell death in development
112. Mitochondria, glutamate neurotoxicity and the death cascade
113. Mitochondria in neurodegeneration: Bioenergetic function in cell life and death
114. Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases
115. Ultrastructural changes in the mitochondria of cerebellar Purkinje cells of nervous mutant mice
116. Differential requirement for caspase 9 in apoptotic pathways in vivo
117. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
118. Apaf1 is required for mitochondrial pathways of apoptosis and brain development